SUBSCRIBE
SUBSCRIBE
News   Drug Development

TRANSGENE Reports 2015 Financial Results And Provides Outlook For 2016

March 8, 2016 | 
1 min read

STRASBOURG, France--(BUSINESS WIRE)--Regulatory News:

Transgene SA (Paris:TNG) today announced its financial results for the fiscal year ended December 31, 2015 and provided an outlook for 2016.

Clinical research Phase II Phase III Earnings Europe
MORE ON THIS TOPIC
3D illustration of a fatty liver
MASH
Aligos Claims Mid-Stage Win in MASH but Investors Are Skeptical
September 20, 2024
 · 
2 min read
 · 
Tristan Manalac
GSK's headquarters office building in Poznan, Poland
Vaccines
GSK Builds Combo Case for RSV, Shingles Shots With Phase III Data
September 19, 2024
 · 
2 min read
 · 
Tristan Manalac
Concept art of a gene therapy showing a syringe injecting into a 3D DNA helix
Gene therapy
4DMT’S Gene Therapy for AMD Clears Phase II, Heads to Late-Stage Studies
September 19, 2024
 · 
2 min read
 · 
Tristan Manalac
Podcast
Sickle Cell Gene Therapies Reach Patients, Moderna Cuts, Obesity Pill Race and ESMO 2024
September 18, 2024
 · 
1 min read
 · 
Heather McKenzie